Dr. Christoph Winterhalter is Chief Business Officer at AGB Biologics. He has three decades of experience in the biopharmaceutical industry. In this role he oversees corporate strategy, business development, new business initiatives, and global marketing for the AGC Biologics CDMO network. Christoph Winterhalter joined AGC Biologics in 2018 and contributed significantly to the company’s growth over the past six years. Before that, he served as the Senior Vice President of Global Business Development for the CDMO Rentschler Biopharma. Reporting directly to the CEO, he guided the company’s global sales and development strategy and created strategic manufacturing alliances with leading global biopharmaceutical companies. While at Rentschler, he was instrumental in tripling the top-line sales numbers for the company. Before that, Christoph Winterhalter worked at Wacker Chemie AG supporting its Life Science businesses for nearly 20 years, most recently serving as Vice President of Biosolutions for the Americas. At Wacker, he managed teams focused on Research and Development (R&D), Project Management, GMP Production, Business Development, and Marketing. Christoph Winterhalter received a degree in Microbiology and his Doctorate from the Technical University of Munich.